R&D
We contribute to promoting human health.
We are the global leader in stem cell therapies
Name of invention
Novel thiazolidinedione derivatives and uses thereof
Registration date
2012.08.02
Registration and application number
No. 10-1172638
Summary
Since it exhibits the activity of inhibiting 15-PGDH that breaks down prostaglandin, it can be effectively used to prevent or treat cardiovascular diseases, gastrointestinal diseases, and kidney diseases, and can be effectively used to prevent hair loss and promote hair growth.
Name of invention
COMPOSITION COMPRISING CELLS TREATED WITH 15-PGDH INHIBITOR OR CULTURE THEREOF AND USE THEREOF
Registration date
2016.10.27
Registration and application number
No. 15771853
Name of invention
Liposuction and SVF separation kit
Registration date
2016.01.20
Registration and application number
No. 10-2016-0007049
Summary
To facilitate the process of collecting fat and a series of processes for separating stem cells to obtain adipose-derived stem cells
Name of invention
Compositions and uses comprising cells treated with 15-PGDH inhibitors or cultures thereof
Registration date
2018.03.16
Registration and application number
No. 10-2018-0030906
Summary
A pharmaceutical composition for the prevention or treatment of atopic diseases comprising cells cultured by adding a 15-PGDH inhibitor to cells expressing PGE2 or a culture thereof (atopic dermatitis)
Name of invention
Compositions and uses comprising cells treated with 15-PGDH inhibitors or cultures thereof
Registration date
2016.10.26
Registration and application number
No. 10-2016-0139967
Summary
A pharmaceutical composition for the prevention or treatment of atopic diseases comprising cells cultured by adding a 15-PGDH inhibitor to cells expressing PGE2 or a culture thereof (atopic dermatitis)
Name of invention
Compositions and uses comprising cells treated with 15-PGDH inhibitors or cultures thereof
Registration date
2018.01.04
Registration and application number
No. 10-2018-0001149
Summary
A pharmaceutical composition for the prevention or treatment of atopic diseases comprising cells cultured by adding a 15-PGDH inhibitor to cells expressing PGE2 or a culture thereof (Rheumatoid arthritis)
Name of invention
Method for mass culturing fat-derived stem cells expressing FoxO
Registration date
2018.12.28
Summary
Composition comprising cells treated with 15-PGDH inhibitor or culture therof and use therof
Name of invention
Medium composition for culturing urine-derived stem cells and method for culturing urine-derived stem cells using the same
Registration date
2019.11.04
Registration and application number
No. 10-2019-0139702
Summary
A culture medium for isolation of urine-derived stem cells, a culture medium for culturing urine-derived stem cells, and a method for separating and culturing urine-derived stem cells using the culture medium
Name of invention
Mass culture method of adipose-derived stem cells expressing anti-aging factors
Registration date
2020.02.03
Registration and application number
No. 10-2020-0012437
Summary
Mass culture method of adipose-derived stem cells expressing anti-aging factors (Foxo1, Foxo3a and Klotho) and medium composition for proliferation and culture of adipose-derived stem cells
Name of invention
A composition for skin regeneration, whitening, antioxidant or wound treatment comprising stem cell-derived exosomes as an active ingredient, and uses thereof
Registration date
2021.02.17
Registration and application number
No. 10-2021-0021026
Summary
A cosmetic composition or pharmaceutical composition for skin regeneration, whitening, antioxidant or wound treatment comprising urine-derived stem cell-derived exosomes as an active ingredient
Name of invention
A medium composition for culturing urine-derived stem cells, a method for separating and culturing urine-derived stem cells using the same, urinary-derived stem cells with improved renal disease treatment function, and a cell therapeutic composition comprising the same
Registration date
2021.09.29
Registration and application number
No. 10-2021-0129299
Summary
A culture medium for isolation and culturing of urine-derived stem cells, a method for separating and culturing urine-derived stem cells using the culture medium, urine-derived stem cells cultured in the culture medium, and a cell therapeutic composition comprising the same
EHLBio Research Institute Certification
European EHLBio trademark
Indonesia EHLBio Trademark Rights
키셀 trademark registration certificate
Kissel trademark registration certificate
Name
Human adipose tissue derived mesenchymal stem cells alleviate atopic dermatitis via regulation of B lymphocyte maturation
Date
2016.11.19
Name
Human Adipose Tissue Derived Mesenchymal Stem Cells Attenuate Atopic Dermatitis by Regulating the Expression of MIP2 miR122a SOCS1 Axis, and Th1 Th2 Responses
Date
2018.11.06
Name
Urine-Derived Stem Cell-Secreted Klotho Plays a Crucial Role in the HK-2 Fibrosis Model by Inhibiting the TGF-β Signaling Pathway
Date
2022.04.30
Name
Production enhancement of human adipose‑derived mesenchymal stem cells by low‑intensity ultrasound stimulation
Date
2022.12.21
Name
In vivo safety and biodistribution profile of Klotho-enhanced human urine-derived stem cells for clinical application
Date
2023.12.10
Name
Combinational Pulsing of TAAs Enforces Dendritic Cell-Based Immunotherapy through T-Cell Proliferation and Interferon-γ Secretion in LLC1 Mouse Model
Date
2024.01.18
